(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Replimune Group, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Friday, July 19th, 2024 | 2024 | Philip Astley-Sparke Chief Executive Officer | 649,000 | 0 | 2,509,486 | 311,520 | 0 | 6,018,364 |
| Friday, July 19th, 2024 | 2023 | Philip Astley-Sparke Chief Executive Officer | 624,000 | 0 | 1,278,200 | 449,280 | 0 | 3,646,550 |
| Friday, July 19th, 2024 | 2024 | Emily Hill Chief Financial Officer | 266,538 | 0 | 1,499,940 | 95,954 | 0 | 3,383,157 |
| Friday, July 19th, 2024 | 2023 | Emily Hill Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, July 19th, 2024 | 2024 | Konstantinos Xynos Chief Medical Officer | 499,200 | 0 | 883,000 | 157,248 | 12,238 | 2,448,364 |
| Friday, July 19th, 2024 | 2023 | Konstantinos Xynos Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, July 26th, 2023 | 2023 | Jean Franchi | 464,500 | 0 | 958,650 | 213,670 | 0 | 2,608,123 |
| Wednesday, July 26th, 2023 | 2023 | Philip Astley-Sparke Chief Executive Officer | 624,000 | 0 | 1,278,200 | 449,280 | 0 | 3,646,550 |
| Wednesday, July 26th, 2023 | 2022 | Philip Astley-Sparke Chief Executive Officer | 600,000 | 0 | 2,697,406 | 280,500 | 0 | 6,366,277 |
| Wednesday, July 26th, 2023 | 2023 | Sushil Patel Chief Strategy Officer | 447,000 | 0 | 958,650 | 205,620 | 12,430 | 2,595,003 |
| Wednesday, July 26th, 2023 | 2022 | Sushil Patel Chief Strategy Officer | 394,167 | 0 | 3,246,238 | 152,650 | 9,527 | 6,952,619 |
| Wednesday, July 27th, 2022 | 2021 | Sushil Patel Chief Commercial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, July 27th, 2022 | 2021 | Philip Astley-Sparke Chief Executive Officer | 533,000 | 0 | 0 | 226,525 | 0 | 2,457,592 |
| Wednesday, July 27th, 2022 | 2022 | Philip Astley-Sparke Chief Executive Officer | 600,000 | 0 | 2,697,406 | 280,500 | 0 | 6,366,277 |
| Wednesday, July 27th, 2022 | 2022 | Sushil Patel Chief Commercial Officer | 394,167 | 0 | 3,246,238 | 152,650 | 9,527 | 6,952,619 |
| Wednesday, July 27th, 2022 | 2021 | Robert Coffin, Ph.D. President and Chief Research & Development Officer | 533,000 | 0 | 0 | 226,525 | 0 | 2,457,592 |
| Wednesday, July 27th, 2022 | 2022 | Robert Coffin, Ph.D. President and Chief Research & Development Officer | 551,500 | 0 | 2,427,397 | 234,388 | 0 | 5,722,547 |
| Thursday, July 22nd, 2021 | 2020 | Philip Astley-Sparke Chief Executive Officer | 437,754 | 0 | 0 | 176,196 | 0 | 2,155,164 |
| Thursday, July 22nd, 2021 | 2020 | Robert Coffin, Ph.D. President and Chief Research & Development Officer | 517,500 | 0 | 0 | 208,294 | 0 | 2,934,145 |
| Thursday, July 22nd, 2021 | 2021 | Andrea Pirzkall | 261,399 | 0 | 0 | 85,262 | 0 | 4,726,571 |
| Thursday, July 22nd, 2021 | 2021 | Philip Astley-Sparke Chief Executive Officer | 533,000 | 0 | 0 | 226,525 | 0 | 2,457,592 |
| Thursday, July 22nd, 2021 | 2021 | Robert Coffin, Ph.D. President and Chief Research & Development Officer | 533,000 | 0 | 0 | 226,525 | 0 | 2,457,592 |
| Wednesday, July 29th, 2020 | 2019 | Howard Kaufman, M.D. Former Chief Medical Officer | 406,000 | 0 | 0 | 142,100 | 0 | 1,875,600 |
| Wednesday, July 29th, 2020 | 2020 | Pamela Esposito, Ph.D. | 362,500 | 0 | 0 | 102,134 | 0 | 1,227,437 |
| Wednesday, July 29th, 2020 | 2020 | Philip Astley-Sparke Chief Executive Officer | 437,754 | 0 | 0 | 176,196 | 0 | 2,155,164 |
| Wednesday, July 29th, 2020 | 2019 | Philip Astley-Sparke Chief Executive Officer | 382,393 | 0 | 0 | 191,198 | 0 | 1,812,591 |
| Wednesday, July 29th, 2020 | 2020 | Robert Coffin, Ph.D. President and Chief Research & Development Officer | 517,500 | 0 | 0 | 208,294 | 0 | 2,934,145 |
| Wednesday, July 29th, 2020 | 2019 | Robert Coffin, Ph.D. President and Chief Research & Development Officer | 477,991 | 0 | 0 | 238,996 | 0 | 2,265,737 |
| Wednesday, July 29th, 2020 | 2020 | Howard Kaufman, M.D. Former Chief Medical Officer | 315,000 | 0 | 0 | 0 | 149,025 | 1,274,660 |
| Wednesday, July 29th, 2020 | 2020 | Jean Franchi | 132,377 | 0 | 0 | 42,625 | 0 | 1,802,202 |
| Friday, August 9th, 2019 | 2018 | Colin Love, Ph.D. Chief Operating Officer | 311,834 | 0 | 0 | 101,784 | 0 | 691,118 |
| Friday, August 9th, 2019 | 2019 | Colin Love, Ph.D. Chief Operating Officer | 310,641 | 0 | 0 | 108,725 | 0 | 1,304,366 |
| Friday, August 9th, 2019 | 2019 | Robert Coffin, Ph.D. President, Chief Executive | 477,991 | 0 | 0 | 238,996 | 0 | 2,265,737 |
| Friday, August 9th, 2019 | 2019 | Howard Kaufman, M.D. | 406,000 | 0 | 0 | 142,100 | 0 | 1,875,600 |
| Friday, August 9th, 2019 | 2018 | Philip Astley-Sparke Executive Chairman, Treasurer, | 254,687 | 0 | 0 | 83,765 | 0 | 504,952 |
| Friday, August 9th, 2019 | 2019 | Philip Astley-Sparke Executive Chairman, Treasurer, | 382,393 | 0 | 0 | 191,198 | 0 | 1,812,591 |
| Friday, August 9th, 2019 | 2018 | Robert Coffin, Ph.D. President, Chief Executive | 389,478 | 0 | 0 | 146,817 | 0 | 1,128,295 |
